USPTO serial 79257706
GARD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 9, 2021
- Examiner
- HELFMAN, JUDITH MICHELLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SE-223 81 Lund, SE
SE-223 81 Lund, SE
SE-223 81 Lund, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
BRADLEY L COHN
BRADLEY L COHN PATTISHALL MCAULIFFE ET AL200 SOUTH WACKER DRIVECHICAGO, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; assays for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic biomarkers for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposes, performed in laboratories, research and scientific use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for scientific testing and screening purposes, performed in laboratories; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes, for scientific testing and screening purposes, and not for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic preparations for medical use; assays for medical use; diagnostic biomarkers for medical use; diagnostic preparations, assays and biomarkers for use in in vitro testing, assessment of toxicological properties of chemical compounds and mixtures, genomic analysis, assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical testing and screening purposes; diagnostic preparations, assays and biomarkers for screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries, all for medical and pharmaceutical medical-based testing and screening purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific industrial analysis and research services in the field of genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification; scientific research and development; conducting research in the field of genomics and animal-free product testing; laboratory services in the field of genomics and animal-free product testing; in vitro analysis and dermal and respiratory analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products for scientific, medical and pharmaceutical research purposes; assessment of toxicological properties of chemical compounds and mixtures, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro skin and respiratory sensitization analysis of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro safety assessments of chemicals, chemical compounds and mixtures, chemical sensitizers, agrochemicals, industrial chemicals, natural extracts, cosmetics and cosmetic ingredients, pharmaceuticals and pharmaceutical candidates, medical devices and materials, consumer products, for medical, pharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification for scientific, medical and pharmaceutical research services and for medical research and scientific research purposes; allergy analysis and animal-free allergy analysis of consumer products, chemical products, cosmetic products, pharmaceutical products and medical products for medical and pharmaceutical purposes; custom development of sensitization assays for prediction and classification of medical sensitizers; safety and potency classification of chemicals, for medical, pharmaceutical and scientific research services; safety and potency testing of cosmetic ingredients; assessment of sensitizers for industry product testing and regulatory purposes in the medical and pharmaceutical industries; in vitro product testing assessment of allergens, in the medical and pharmaceutical industries; sensitization product testing for the pharmaceutical, cosmetic and chemical industry; information, advisory and consultancy services relating to genomics, in vitro and animal free testing, testing of toxicological properties of chemical compounds and mixtures and chemical sensitizers, screening of products, materials and substances for sensitizers, allergens and potency classification, product testing assessment of toxicological properties of chemical compounds and mixtures for medical and pharmaceutical research purposes; animal-free product testing of chemical compounds, genomic product testing, animal-free genomic product testing, dermal and respiratory in vitro product testing and analysis, in vitro skin and respiratory sensitization product testing and analysis, in vitro product safety assessments, product testing and assessment of sensitizers, in vitro product testing for assessment of chemical skin sensitizers, respiratory sensitizers and potency classification, all for medical and pharmaceutical product safety purposes; screening of pharmaceutical candidates, safety and potency classification of chemicals, safety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries and for medical research and scientific purposes; safety assessment of chemicals and proteins, in vitro assessment of allergens, all for medical and pharmaceutical purposes and for medical research and scientific purposes; sensitization product testing for the pharmaceutical and cosmetic industries; in vitro safety and toxicity testing of medical devices | ACTIVE | — |
| 044 | In vitro testing for medical and pharmaceutical diagnostic purposes and information, advisory and consultancy services relating thereto; allergy testing and animal-free allergy testing, all for medical and pharmaceutical diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SenzaGen AB
- Other trademarks owned by SenzaGen AB
- Other trademarks owned by SenzaGen AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GARD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 15, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 9, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 24, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 24, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 4, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 4, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 4, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jul 19, 2021 | EXDM | EXPARTE APPEAL DISMISSED AS MOOT | — |
| Nov 3, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 7, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 11, 2020 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Aug 11, 2020 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Aug 11, 2020 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Aug 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 21, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 21, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 21, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 21, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jan 22, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 22, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 22, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 7, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 7, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |